A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.

Lee, Joo-Heung; Youn, Jai-Il; Kim, Tae-Yoon; Choi, Jee-Ho; Park, Chul-Jong; Choe, Yong-Beom; Song, Hae-Jun; Kim, Nack-In; Kim, Kwang-Joong; Lee, Jeung-Hoon; Yoo, Hyun-Jeong

A multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in patients with moderate to severe psoriasis.

Lee, Joo-Heung; Youn, Jai-Il; Kim, Tae-Yoon; Choi, Jee-Ho; Park, Chul-Jong; Choe, Yong-Beom; Song, Hae-Jun; Kim, Nack-In; Kim, Kwang-Joong; Lee, Jeung-Hoon; Yoo, Hyun-Jeong.

Afiliação

Lee JH; Department of Dermatology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul, Korea. joosoo@skku.edu.
Youn JI; Department of Dermatology, National Medical Center, Seoul, Korea.
Kim TY; Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Choi JH; Department of Dermatology, Asian Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Park CJ; Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Choe YB; Department of Dermatology, Konkuk University School of Medicine, Seoul, Korea.
Song HJ; Department of Dermatology, College of Medicine, Korea University, Seoul, Korea.
Kim NI; Department of Dermatology, College of Medicine, Kyung Hee University, Seoul, Korea.
Kim KJ; Department of Dermatology, Hallym University Sacred Heart Hospital, Seoul, Korea.
Lee JH; Department of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea.
Yoo HJ; Pfizer Pharmaceuticals Korea Limited, Seoul, Korea.

BMC Dermatol ; 16(1): 11, 2016 07 25.

Article em En | MEDLINE | ID: mdl-27455955

Assuntos

Acitretina/administração & dosagem; Anti-Inflamatórios não Esteroides/administração & dosagem; Etanercepte/administração & dosagem; Imunossupressores/administração & dosagem; Ceratolíticos/administração & dosagem; Psoríase/tratamento farmacológico; Adulto; Método Duplo-Cego; Quimioterapia Combinada; Feminino; Humanos; Imunoglobulina G/uso terapêutico; Coreia (Geográfico); Masculino; Pessoa de Meia-Idade; Projetos Piloto; Receptores do Fator de Necrose Tumoral/uso terapêutico; Índice de Gravidade de Doença

Palavras-chave

Acitretin; Combination therapy; Efficacy; Etanercept; Korean patients; Psoriasis; Safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Anti-Inflamatórios não Esteroides / Acitretina / Etanercepte / Imunossupressores / Ceratolíticos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google